Dopaminergic Neuron Identification via Gene Expression Classification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods struggle to accurately identify dopaminergic precursor cells within in vitro populations of neuronal progenitor cells, particularly during differentiation stages where definitive biomarkers are unavailable, hindering the efficiency and success of cell therapy for neurodegenerative diseases like Parkinson's.
Innovation Solution
A computer-implemented method that receives gene expression data from in vitro neuronal progenitor cells, compares it to a reference database using metagenes and supervised classification models, and outputs a classification indicating the presence of dopaminergic precursor cells based on probability and deviation scores, enabling precise identification even in stages lacking clear biomarkers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional biomarker-based identification methods are used, then the process is simple and fast, but the identification accuracy fails during differentiation stages where definitive biomarkers are unavailable
Solution Approach 1:
The patent transforms the identification approach from relying on single biomarker parameters to analyzing multiple gene expression parameters simultaneously. By measuring and comparing expression levels of multiple genes (e.g., LMX1A, FOXA2, TH) and computing composite scores (NeuroScore, Novelty Score), the system achieves accurate identification during differentiation stages when individual biomarkers are insufficient or unavailable.
Solution Approach 2:
The patent creates a composite identification model that integrates multiple gene expression profiles, statistical parameters, and classification algorithms. Rather than using a single biomarker, the system combines data from multiple genes and computational methods (supervised classification, deviation scoring) to form a comprehensive identification framework that maintains accuracy across all differentiation stages.
2Measurement precision
If comprehensive gene expression analysis is performed, then identification accuracy improves, but the computational complexity and time required increase
Solution Approach 1:
The patent performs preliminary actions by pre-processing gene expression data into standardized formats, pre-calculating reference profiles for different cell types and differentiation stages, and pre-establishing statistical models before actual identification is needed. This allows the system to quickly compare new samples against pre-computed references, reducing analysis time while maintaining comprehensive gene expression analysis.
Solution Approach 2:
The patent replaces manual or simple mechanical identification methods with automated computational systems. By using computer-implemented algorithms for data processing, statistical analysis, and classification, the system handles complex multi-gene analysis efficiently, reducing the time burden that would otherwise result from manual interpretation of comprehensive gene expression data.
3Reliability
If comprehensive gene expression data is collected and analyzed, then identification reliability improves, but the data processing complexity and computational resources required increase
Solution Approach 1:
The patent extracts only the most relevant and informative gene expression data from comprehensive datasets. By identifying and focusing on key genes and expression patterns that are most indicative of dopaminergic precursor cell identity, the system reduces data processing complexity while maintaining high identification reliability. This selective extraction approach filters out redundant information while preserving critical identification signals.
Data Source
AI summary
Provided herein are, inter alia, methods of assaying neuronal progenitor cell populations derived from iPSCs, thereby providing for a user friendly molecular diagnostic tool for neuronal cell types, including dopaminergic neurons. The methods provided are valuable for the efficient and precise characterization of identity and functionality of iPSC-derived dopaminergic neurons prior to their clinical application such as the treatment of Parkinson's disease or Multiple Sclerosis.